Xueyin Zu
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells.
Journal: Journal of pharmacological sciences
Published: September 14, 2020
2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 22, 2020
Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: May 11, 2019
Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells.
Journal: Phytotherapy research : PTR
Published: March 26, 2019
Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-kB Activity in Triple-Negative Breast Cancer Cells.
Journal: Molecules and cells
Published: March 04, 2019
Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2.
Journal: Phytotherapy research : PTR
Published: August 23, 2018
Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.
Journal: Molecular carcinogenesis
Published: August 21, 2018
Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient-derived esophageal tumor growth.
Journal: Molecular carcinogenesis
Published: July 04, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026